Liquid biopsy is a revolutionary molecular diagnostic tool that allows scientists to detect genetic abnormalities or monitor disease progression non-invasively. However, clinicians encounter several ...

An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...

To overcome this critical bottleneck, researchers have been pursuing the new concept of “liquid biopsies,” which involves the easy extraction of blood or other body fluids using non-invasive ...

There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...

Since the discovery of cell-free DNA (cfDNA) in 1948, shedded DNA fragments have been applied to technologies ranging from pre-natal genetic screening and ...

In a paper recently published in the journal Acta Neuropathologica Communications, DetermaCNI showed promise as a liquid biopsy method for diagnosing and profiling central nervous system tumors by ...

In a statement, the UK medical device firm said its "liquid biopsy" approach "offers the prospect of a new era of personalised cancer care" and moves it closer to positioning Parsortix as a go-to ...

Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating ...

Exosomes have been reported in all biological fluids, including blood, plasma, serum, urine ... custom molecular solutions for their liquid biopsy needs, including clinical research services ...

The findings of Thompson and co-workers have prompted some to dismiss PSA as useless for identification of prostate cancer and to suggest biopsy of all men aged 55-75 years - approximately 30 ...